Characteristics
|
A convenient set consisting of seven inhibitors useful for the study of MAP Kinase signaling pathway. The seven inhibitors are: 1 mg of PD 184352 (ABIn628981), 5 mg of PD 98059 (ABIN412263), 1 mg of SB 203580 (ABIN412316), 25 mg of Sorafenib (ABIN412186), 5 mg of SP 600125 (ABIN412267), 5 mg of U0126 (ABIN412266), and 1 mg of ZM 336372 (ABIN629086).
|